Children and Adolescents With Marfan Syndrome: 10,000 Healthy Steps and Beyond
Primary Purpose
Marfan Syndrome
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Exercise
Sponsored by
About this trial
This is an interventional prevention trial for Marfan Syndrome
Eligibility Criteria
Inclusion Criteria:
- 10-19 years of age,
- MFS by revised Ghent criteria,
- Cardiac clearance to exercise by the primary cardiologist.
Exclusion Criteria:
- Ventricular dysfunction,
- Prior history of aortic surgery.
Sites / Locations
- Stanford Children's Health
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
10,000 Steps/day for Pediatric Marfan Patients
Arm Description
Participants will be given a Garmin VivoFit and asked to take at least 10,000 steps per day. A study coordinator will reach out at least once per week to check in on progress made and help make weekly goals.
Outcomes
Primary Outcome Measures
To determine if 6 months of regular physical activity improves aortic stiffness in MFS patients. exercise, a decrease in expressed biomarkers, and an increase in COPE scores of MFS patients.
The investigators' primary outcome measure is aortic stiffness measured by arterial tonometry (pulse wave velocity).
Secondary Outcome Measures
To determine if 6 months of regular physical activity improves aortic stiffness and the biomarker profile in MFS patients.
The secondary outcomes include aortic stiffness at the aortic root at the level of the sinuses of Valsalva and ascending aorta.
To determine if 6 months of regular physical activity improves aortic stiffness and the biomarker profile in MFS patients.
Secondary outcomes will be expression levels of TGF-β, Ang-II, MMP-2 & -9, ROS levels.
To determine if 6 months of regular physical activity decreases aortic stiffness and rate of aortic root dilation in Marfan mice.
Secondary outcomes will be expression levels of TGF-β, MMP-2, MMP-9, and ROS.
To determine if 6 months of regular physical activity improves coping skills in Marfan patients.
The outcome measure is the COPE inventory score.
Full Information
NCT ID
NCT03567460
First Posted
October 3, 2017
Last Updated
July 23, 2020
Sponsor
Stanford University
Collaborators
Midwestern University
1. Study Identification
Unique Protocol Identification Number
NCT03567460
Brief Title
Children and Adolescents With Marfan Syndrome: 10,000 Healthy Steps and Beyond
Official Title
Children and Adolescents With Marfan Syndrome: 10,000 Healthy Steps and Beyond
Study Type
Interventional
2. Study Status
Record Verification Date
July 2020
Overall Recruitment Status
Completed
Study Start Date
January 1, 2017 (Actual)
Primary Completion Date
December 31, 2019 (Actual)
Study Completion Date
December 31, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Stanford University
Collaborators
Midwestern University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Marfan patients are at risk of sudden death due to weakening of the wall of the large blood vessel leading from the heart (aorta). The wall of the aorta weakens and dilates which can rupture, leading to death, and sometimes during intense exercise.
There is some evidence in Marfan patients that a stiffer aorta increases risk for rupture.
For some time, clinical care has focused on what type of exercise these patients should avoid due to risk for aortic dissection. Little clinical emphasis has been placed on encouraging patients to engage in routine and safe exercise such as walking. Informed by this evidence, the investigators propose to collaboratively investigate whether regular exercise improves aortic health in adolescent Marfan patients.
Detailed Description
Marfan syndrome is an inherited disorder of the connective tissue, which provides material and support for the skeleton, muscles, and blood vessels. Marfan patients are at risk of sudden death due to weakening of the wall of the large blood vessel leading from the heart (aorta). The wall of the aorta weakens and dilates which can rupture, leading to death, and sometimes during intense exercise.
Typically, the weakening process starts when elastin fibers in the aorta become fragmented. There is some evidence in Marfan patients that a stiffer aorta increases risk for rupture.
For some time, clinical care has focused on what type of exercise these patients should avoid due to risk for aortic dissection. Little clinical emphasis has been placed on encouraging patients to engage in routine and safe exercise such as walking. These young patients also frequently choose sedentary lifestyles, most likely due to limitations imposed by parents as well as adolescents' own perceptions of what is safe for them and their physical capabilities. Another complicating factor is that these patients often experience difficulty coping with their diagnosis. Informed by this evidence, the investigators propose to collaboratively investigate whether regular exercise improves aortic health and coping skills in adolescent Marfan patients.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Marfan Syndrome
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
24 (Actual)
8. Arms, Groups, and Interventions
Arm Title
10,000 Steps/day for Pediatric Marfan Patients
Arm Type
Experimental
Arm Description
Participants will be given a Garmin VivoFit and asked to take at least 10,000 steps per day. A study coordinator will reach out at least once per week to check in on progress made and help make weekly goals.
Intervention Type
Behavioral
Intervention Name(s)
Exercise
Intervention Description
Across studies in adolescents in general population, 60 minutes of recommended daily exercise level is achieved, on average, within a total volume of 10,000-11,700 steps. The investigators will assess baseline physical activity quantitatively by using an accelerometer worn on the wrist during waking hours over a 7-day period. Each participant will be given a Garmin device to place on their wrist that will track their steps. Then patients will be asked to complete 10,000 steps daily for 6 months (acclimation over a week), which will be encouraged by daily text messages or e-mail, and weekly phone calls by the intervention team in addition to a Garmin and Facebook peer group.
Primary Outcome Measure Information:
Title
To determine if 6 months of regular physical activity improves aortic stiffness in MFS patients. exercise, a decrease in expressed biomarkers, and an increase in COPE scores of MFS patients.
Description
The investigators' primary outcome measure is aortic stiffness measured by arterial tonometry (pulse wave velocity).
Time Frame
6 months of intervention
Secondary Outcome Measure Information:
Title
To determine if 6 months of regular physical activity improves aortic stiffness and the biomarker profile in MFS patients.
Description
The secondary outcomes include aortic stiffness at the aortic root at the level of the sinuses of Valsalva and ascending aorta.
Time Frame
6 months of intervention
Title
To determine if 6 months of regular physical activity improves aortic stiffness and the biomarker profile in MFS patients.
Description
Secondary outcomes will be expression levels of TGF-β, Ang-II, MMP-2 & -9, ROS levels.
Time Frame
6 months of intervention
Title
To determine if 6 months of regular physical activity decreases aortic stiffness and rate of aortic root dilation in Marfan mice.
Description
Secondary outcomes will be expression levels of TGF-β, MMP-2, MMP-9, and ROS.
Time Frame
6 months of intervention
Title
To determine if 6 months of regular physical activity improves coping skills in Marfan patients.
Description
The outcome measure is the COPE inventory score.
Time Frame
6 months of intervention
10. Eligibility
Sex
All
Minimum Age & Unit of Time
10 Years
Maximum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
10-19 years of age,
MFS by revised Ghent criteria,
Cardiac clearance to exercise by the primary cardiologist.
Exclusion Criteria:
Ventricular dysfunction,
Prior history of aortic surgery.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Seda Tierney, MD
Organizational Affiliation
Stanford University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Stanford Children's Health
City
Palo Alto
State/Province
California
ZIP/Postal Code
94306
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Children and Adolescents With Marfan Syndrome: 10,000 Healthy Steps and Beyond
We'll reach out to this number within 24 hrs